Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis.
Citrome LeslieMariacristina CastelliMasami HasebeTakaaki TeraharaJustin FadenMarina KomaroffPublished in: Neuropsychiatric disease and treatment (2024)
Post hoc analysis using a PANSS five-factor model suggests that HP-3070 may address a broad range of symptoms in people with schizophrenia.